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ABSTRACT In adult respiratory distress syndrome, the primary function of pulmonary surfactant to strongly reduce the
surface tension of the air-alveolar interface is impaired, resulting in diminished lung compliance, a decreased lung volume, and
severe hypoxemia. Dysfunction coincides with an increased level of cholesterol in surfactant which on its own or together with
other factors causes surfactant failure. In the current study, we investigated by atomic force microscopy and Kelvin-probe force
microscopy how the increased level of cholesterol disrupts the assembly of an efﬁcient ﬁlm. Functional surfactant ﬁlms
underwent a monolayer-bilayer conversion upon contraction and resulted in a ﬁlm with lipid bilayer stacks, scattered over a lipid
monolayer. Large stacks were at positive electrical potential, small stacks at negative potential with respect to the surrounding
monolayer areas. Dysfunctional ﬁlms formed only few stacks. The surface potential of the occasional stacks was also not
different from the surrounding monolayer. Based on ﬁlm topology and potential distribution, we propose a mechanism for
formation of stacked bilayer patches whereby the helical surfactant-associated protein SP-C becomes inserted into the bilayers
with deﬁned polarity. We discuss the functional role of the stacks as mechanically reinforcing elements and how an elevated
level of cholesterol inhibits the formation of the stacks. This offers a simple biophysical explanation for surfactant inhibition in
adult respiratory distress syndrome and possible targets for treatment.
INTRODUCTION
Lung compliance is dominated by the surface tension of the
hydration layer covering the lung epithelium to the air (1). The
air-water interface is covered by a tightly packed molecular
ﬁlm of pulmonary surfactant. The ﬁlm hinders the interface
from contracting under the inﬂuence of the surface tension. It
thus reduces the surface tension from;72mN/m of a bare air-
water interface to,1mN/m once the air-lung interface is at its
minimum size at end expiration (2). The surface tension likely
always remains ,10 mN/m during tidal breathing in the
healthy lung (3). A low surface tension is required to reduce
theLaplace pressure, which otherwisewould cause the alveoli
to collapse into the small airways.
In adult respiratory distress syndrome (ARDS), pulmo-
nary surfactant function is inhibited. As a result, the surface
tension is elevated and the lung function substantially im-
paired. ARDS is a common and devastating condition with
150,000 cases per year in the US and a mortality rate of
;30%. Because surfactant impairment is likely a major fac-
tor for the morbidity and mortality of ARDS, it has been
targeted by replacement surfactant therapy. However, suc-
cess has been minimal (for a review, see (4)) because the ex-
ogenous surfactant apparently also became inactivated. A
better understanding of the cause and mechanism of the in-
activation may therefore be required to counter it more
speciﬁcally.
Until recently, surfactant inhibition in ARDS has been
investigated mainly with regard to serum proteins, which are
highly elevated in the alveolar space in the case of ARDS
(e.g., (4–6)) and oxidative inactivation by reactive oxygen
species (7–10). Here, we focus on the role of cholesterol in
surfactant. Karagiorga et al. (11) recently reported an in-
crease of cholesterol in surfactant from ARDS patients over
control (8.5 6 5% w/w) from 15.6 6 2% w/w up to 43 6
22% w/w. Cholesterol in surfactant is also increased to 20%
w/w in animal models of lung injury (12). For such elevated
levels of cholesterol, the lowest surface tension observed by
us in vitro is 16 mN/m (13). At a surface tension of 16 mN/m,
the alveoli recede from a spherical shape into shallow cav-
ities in the terminal airways and the gas exchange area is
reduced to less than one-half of its normal value (3). It was
therefore concluded that an elevated level of cholesterol abol-
ishes surfactant function.
In this study, we show by atomic force microscopy (AFM)
and Kelvin probe force microscopy (KPFM) that failure of
surfactant function in the presence of 20% w/w cholesterol
coincides with a distinct change in the molecular architecture
of the interfacial ﬁlm. KPFM is an imaging mode of AFM
and produces a map of the local electrical surface potential in
addition to a topographical AFM image. For ﬁlms of amphi-
philic molecules, the electrical surface potential is a footprint
of the molecular species and/or their molecular order under
the tip (14–17) and arises from the alignment of molecular
dipoles m, upon packing of the ﬁlm (18). More speciﬁcally,
the surface potential is a function of the component of m nor-
mal to the interface, the dielectric constant e of the environment
Submitted February 9, 2007, and accepted for publication March 27, 2007.
Address reprint requests to M. W. Amrein, Tel.: 403-210-8177; E-mail:
mamrein@ucalgary.ca.
Editor: Lukas K. Tamm.
 2007 by the Biophysical Society
0006-3495/07/07/674/10 $2.00 doi: 10.1529/biophysj.107.106310
674 Biophysical Journal Volume 93 July 2007 674–683
of the dipoles, and the packing density of molecules (dipoles)
or surface area A occupied by each molecule. For phospho-
lipids, contributions have been ascribed to various regions of
the molecules, each in its own dielectric environment—the
headgroup region, the aliphatic tail, and the terminal methyl
group (18). For example, ﬁlms of dipalmitoylphosphatidyl-
choline, the most abundant of the surfactant components, has
been reported to give rise to a surface potential of;500 mV,
at the surface tensions used in this study (26 mN/m) (19). In a
ﬁlm composed of many components like pulmonary surfac-
tant, the local differences in electrical surface potential reﬂect
the differences in local sample composition, but also packing
and ordering of the molecules in an area (20).
Films for this study were formed from bovine lipid extract
surfactant (BLES). BLES is a clinically used replacement
surfactant. BLES differs from natural surfactant in the lack
of the hydrophilic surfactant-associated proteins SP-A and
SP-D as well as cholesterol. It consists of ;80% by weight
of phosphatidylcholines with dipalmitoylphosphatidylcho-
line (DPPC) and 1-palmitoyl-2-oleoyl-phosphatidylcholine
being the major molecular species and dipalmitoylphospha-
tidylglycerol and 1-palmitoyl-2-oleoyl-phosphatidylglycerol
being present at signiﬁcant levels. It also contains phospha-
tidylethanolamine, phosphatidylinositol, sphingomyelin, trace
amounts of lyso-phosphatidic acids, and vitamin E as well as
the small hydrophobic surfactant-associated proteins SP-B
and SP-C (21). Cholesterol, which is removed from BLES,
is the major neutral lipid in mammalian surfactant at 5–10%
w/w. In the current study, ﬁlms were prepared from unaltered
BLES, from BLES with 5% w/w cholesterol added (re-
ﬂecting normal surfactant), and BLES with 20% w/w cho-
lesterol added (reﬂecting surfactant in ARDS).
MATERIALS AND METHODS
Preparation of the surfactants
BLES in nonbuffered normal saline (pH 5–6) with a phospholipid concen-
tration of 27 mg/ml was a gift by the manufacturer (BLES Biochemical,
London, Ontario). Cholesterol was purchased from Sigma Chemicals (St.
Louis, MO). A solution of 1:1:1 ratio of methanol, chloroform, and BLES by
volume was ﬁrst vortexed and then centrifuged at 100 g for 5 min. The
methanol/water phase was discarded and the BLES in chloroform was re-
tained and none, 5% w/w, or 20% w/w of cholesterol, with respect to phos-
pholipids,was added. Each solutionwas then dried underN2 and resuspended
with buffer (140 mM NaCl, 10 mM HEPES, and 2.5 mM CaCl2; pH 6.9)
to obtain an aqueous suspension of BLES and cholesterol at a concentration
of 27 mg/ml phospholipids.
Film deposition
For the microscopy, the ﬁlms were deposited onto freshly cleaved mica
(ruby, ASTMV-2 quality, Asheville-Schoonmaker Mica, Newport News,
VA) by the Langmuir-Blodgett technique. Surfactant suspensions were
spread at the air-buffer interface (750 cm2) of a Langmuir trough (Nima
Technology, Coventry, England) at room temperature. The ﬁlm area was
reduced or expanded at a rate of 100 cm2/min, the surface tension contin-
uously monitored, and area-surface tension isotherm recorded (Fig. 1). For
results shown in Figs. 2–5 and 6, ﬁlms were contracted or expanded before
deposition by deﬁned amounts as described in the following section. For
deposition, a mica support was ﬁrst lowered across the interface at a speed of
45 mm/min and then retracted at 25 mm/min. A ﬁlm was deposited upon the
upstroke while the surface tension was kept constant.
For the ﬁlms shown in Fig. 4 or discussed in the Results, a ﬁrst sample of
each ﬁlm was deposited onto mica upon the ﬁlm contraction at a surface
tension of g ¼ 34 mN/m (denoted by 1 in Fig. 1, denoted expanded in
Fig. 4). A second sample was collected at g ¼ 26 mN/m in a similar way
(denoted by 2 in Fig. 1, denoted contracted in Fig. 4). A third sample was
collected at g ¼ 34 mN/m (denoted by 3 in Fig. 1, denoted re-expanded
in Fig. 4) after the ﬁlm area had been reexpanded. The collection points were
chosen such that upon area reduction, the ﬁrst sample was taken before the
onset of a shoulder in area-surface tension isotherm, the second sample at
the end of the shoulder, and the third sample after a partial reexpansion of the
ﬁlm (Fig. 1). For the results shown in Figs. 5 and 6, ﬁlms were obtained
similar to collection point 2 (after;50% area reduction from the onset of the
shoulder in surface tension isotherm).
Microscopy
AFM topographical images were collected in air with a NanoWizard AFM
(JPK Instruments, Berlin, Germany) using noncontact mode silicon cantile-
vers NCH-20 from NanoWorld with typical spring constants of 21–78 N/m,
and resonance frequencies of 260–460 kHz.
Surface potential maps and corresponding topographical images were
acquired on two different instruments employing two different methods of
measuring the electrical surface potential. Both methods revealed similar
potentials for corresponding ﬁlm areas. The data displayed in Fig. 5, A and
B, and Fig. 6 A were collected in air with a NanoWizard AFM. The images
were acquired by tracing the sample areas line by line. On trace, the sample
the topography was measured in intermittent contact mode. On the return
pass (retrace), the height information was used to maintain the cantilever at a
FIGURE 1 Area-surface tension isotherm of BLES upon sample collec-
tion. The solid black line denotes the isotherm. Upon contraction of the ﬁlm,
the surface tension ﬁrst dropped steeply before ﬂattening into a shoulder of
the isotherm. At the inﬂection point, a ﬁrst sample was collected (denoted by
1). The ﬁlm transfer is visible as a short horizontal stretch in the isotherm.
The ﬁlm area was then further reduced until the surface tension started to
drop more steeply again, at which point a second sample was collected (2).
After transfer of the second sample, the ﬁlm was reexpanded and a third
sample collected (3). Dotted lines denote the likely progression of the
isotherm in the absence of sample collection. The expected progression was
deduced from an isotherm of this ﬁlm acquired before collection of the
samples.
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constant offset height above the surface and the electrical surface potential
measured as described (22). Conductive cantilevers (Type BS-ElectriTap300,
BudgetSensors, Soﬁa, Bulgaria) were used and connected to an external cir-
cuit to control the tip potential. The high magniﬁcation image of Fig. 6 Bwas
acquired, using a laboratory-built setup described in the literature (23,24).
With this setup, potential and topography were measured simultaneously,
using the frequency modulation technique (FM-KPFM). This method derives
a surface potential by measuring the gradient of the electrostatic force rather
than the force itself and is largely insensitive to the geometry of the tip.
The potential maps in this study show relative values. A value of 0 V was
assigned to the most negative value in each of the maps displayed. The
absolute potentials are measured by the instruments, but carry an offset due
to a contact potential, brought about by the sample support to which the
measured potential is referred. This is discussed in Leonenko et al. (20).
Quantitative image analysis
The total area of lipid leaﬂets within bilayer stacks in the AFM micrographs
was computed to determine the extent by which the surfactant monolayer
folded into stacks of bilayers upon the area reduction between collection
points 1 and 2. For the analysis, it was assumed that the lowest topographical
level in each micrograph represented a lipid monolayer. Hence, the image
size equaled the monolayer area. A plateau;5 nm above the monolayer was
considered a lipid bilayer (i.e., two leaﬂets of lipid monolayer) on top of the
monolayer; a plateau of 10 nm height was considered a monolayer with two
bilayers on top of each other; etc. The total amount of lipid leaﬂets within
bilayer stacks was then related to the area change that has occurred within
the shoulder of the area-surface tension isotherm. For example, if the ﬁlm
area had been reduced by half between collection points 1 and 2, and the area
of lipid leaﬂets within bilayer stacks summed up to be similar to the image
size, the monolayer-bilayer conversion was considered 100%.
For each concentration of cholesterol in BLES and each of the three col-
lection points, four micrographs from two independent experiments were an-
alyzed.
RESULTS
Structure-function relationship of
the surfactant ﬁlms
The structures formed by surfactant ﬁlms containing none,
5%, or 20% w/w cholesterol were related to our earlier func-
tional study on these ﬁlms (13). Films containing none or
5% reduce the surface tension close to zero mN/m and are
considered functional. Films containing 20% cholesterol are
unable to lower the surface tension below ;16 mN/m. A
surface tension of 16 mN/m is not low enough for proper
lung function.
The functional surfactants show lamellar structures scat-
tered over the monolayer surface (Fig. 3). Each step in a stack
is 5 nm high, indicative of a single lipid bilayer. The bilayer
stacks form from the monolayer upon contraction. This
monolayer-multilayer conversion corresponds to a shoulder
in the area-surface tension isotherm (Fig. 1, see also (13)),
where the surface tension changes little upon a change of
;25–50% in surface area. Before the shoulder, the ﬁlms show
none or only a few lamellar structures (Fig. 4, A and B, ex-
panded). At the end of the shoulder, the bilayer stacks have
fully established (Fig. 4, A and B, contracted). Our earlier
functional study of these samples show that, at this point, the
ﬁlms have become incompressible and the surface tension
drops steeply, often to ,1 mN/m upon further ﬁlm contrac-
tion (13). Formation of lamellar structures is reversible: the
lamellar structures unfold into the monolayer (Fig. 4, A and B,
re-expanded).
FIGURE 2 The discrete levels of lipid bilayer patches on top of each other were identiﬁed in each AFM micrograph in the histogram of the area count over
topographical height using ImageJ (Wayne Rasband, National Institutes of Health, Bethesda, MD). In this example, a maximum of nine discrete levels of
bilayers were identiﬁed.
FIGURE 3 AFM micrograph in three-dimensional rep-
resentation of surfactant containing 5% w/w cholesterol
(5 mm 3 5 mm). The ﬁlm shows stacks of bilayers up to
three layers high. Each layer is ﬁve nanometers high.
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The amount of area reduction required to reach a surface
tension of 26 mN/m varied between ;40% and 50% of the
area after the ﬁrst sample was collected. The amount of re-
expansion required to reach a surface tension of 34 mN/m
was also different for each ﬁlm and varied from;50–30% of
the area change that had previously occurred between col-
lection points 1 and 2. The amount of reexpansion was less
than the previous contraction because of a hysteresis be-
tween the contraction and expansion trace (Fig. 1; i.e., the
surface tension rose faster on the expansion as it had pre-
viously dropped on contraction). For the ﬁlm shown in Fig. 4
A, the area between sample collections has been reduced
from the expanded state (100%) to ;50% and then was
reexpanded to ;75% for collection of the ﬁlm denoted ‘‘re-
expanded.’’ The variability between isotherms of similar
samples is discussed in Gunasekara et al. (13).
For ﬁlms containing 20% cholesterol, the AFM micro-
graphs reveal almost no lamellar structures (Fig. 4 C). Lack
FIGURE 4 AFM topographies (20 mm3 20 mm) of BLES containing no cholesterol (A), 5% w/w cholesterol (B), and 20% w/w cholesterol (C). The ﬁlms
denoted ‘‘expanded’’ have been collected from the Langmuir trough after the ﬁlm was spread and allowed to contract up to the onset of a shoulder in the
area-surface tension isotherm (g ¼ 34 mN/m, see Fig. 1). Then, the ﬁlm area was further reduced and another sample collected (denoted contracted; (g ¼
26 mN/m)). The images in the right column have been acquired from ﬁlms after a partial reexpansion (g ¼ 34 mN/m). Films containing no or 5% cholesterol
formed stacks of lipid bilayer patches, attached to the monolayer. The bilayer patches reintegrated in the monolayer when the ﬁlm was reexpanded. Note that
the reexpanded ﬁlms of panels A and B still show some bilayer stacks because the area was only partially reexpanded. Films with 20% cholesterol formed
almost no lipid bilayer stacks and continuously collapsed during contraction (C).
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of lamellar structures is consistent with a continuous, irre-
versible collapse of monolayer matter into the aqueous phase
upon contraction of the ﬁlm. The area reduction required to
reach 26 mN/m was only;20% for the ﬁlms containing 20%
cholesterol. We therefore also collected ﬁlms after ;50%
area reduction, at which point the surface tension had dropped
to;20 mN/m. These ﬁlms too were devoid of bilayer stacks
(not shown).
Quantitative analysis of the micrographs from expanded
and contracted ﬁlms allowed for an estimate of the propor-
tion of lipids that underwent a monolayer-bilayer conversion
over the lipids that were lost to the aqueous phase upon ﬁlm
contraction (Fig. 2; and see Materials and Methods). The
estimate was based on the analysis of four micrographs such
as shown in Fig. 4 for each condition. According to this
analysis, for surfactant containing no cholesterol, 100% of
the lipids in the monolayer displaced from the interface were
recovered in bilayer stacks. Individual micrographs ranged
from 100 to 103% recovery. For ﬁlms containing 5% w/w
cholesterol, ;12% of the squeezed lipids were lost to the
subphase and, hence, ;88% converted into stacks of bi-
layers after the ﬁlm area had been reduced by half. Individual
micrographs ranged from 5 to 18% loss. For ﬁlms containing
20% w/w cholesterol, .90% of the lipids were lost to the
aqueous phase upon contraction.
The structure of the bilayer stacks as
revealed by Kelvin probe force microscopy
Fig. 5 shows the topography (left) and local electrical surface
potential (right) of ﬁlms containing no cholesterol. Both the
topographical map and the electrical surface potential map
(right) are highly structured for these ﬁlms, and the dynamic
range of the electrical signal is 300–400 mV. Large stacks of
bilayer patches are at a potential of up to 200 mV above the
monolayer. Upon close inspection of Fig. 5 A, including the
cross-sections below the respective images, the potential
is not strictly correlated with topographical height (i.e., ﬁlm
FIGURE 5 (A) Overview of a ﬁlm of
BLES that contains no cholesterol. The
topographical image (left, and cross sec-
tion below) shows a pattern of monolayer
and scattered multilayer regions. In the
potential map (right, and cross section
below) large stacks of bilayer patches are
at a potential of up to 200 mV above the
monolayer. The arrows in the topograph-
ical image and in the potential map point
to a region, where the topographical
height does not change but the potential
shows two distinct levels. (B) BLES ﬁlm
at higher magniﬁcation. The outer pe-
rimeters of the bilayer stacks from the
topological image (left) are overlaid in
red in the potential map (right). The
larger of the bilayer stacks are at positive
potential with respect to the monolayer.
Small stacks are up to;100mV lower in
the electrical potential than average.
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thickness). Sometimes the potential even drops to a lower
level within an area of constant topographical height (arrows
in Fig. 5 A).
Fig. 5 B shows the ﬁlm at higher magniﬁcation. To allow
for easy correlation between topology and potential, the outer
perimeters of the bilayer stacks were computed from the
AFM topographical image (Fig. 5 B, left) and overlaid in red
in the potential map (Fig. 5 B, right). Interestingly, only the
larger, irregularly shaped bilayer-stacks are always at a more
positive voltage with respect to the average potential. Smaller
stacks have an almost spherical perimeter. The stacks be-
tween 200 and 400 nm in diameter are either at a more
negative or more positive potential. Smaller stacks are up to
;100 mV below average potential.
The most striking feature in the surface potential maps is
the either positive or negative surface potential of the stacks
of lipid bilayers with respect to the monolayer areas. The
large contributions of the stacks to the surface potential may
not likely be ascribed to lipids. The lipids of the two leaﬂets
of a bilayer are of opposite orientation with respect to the
sample plane such that the contribution to the surface
potential cancels out. Rather, the surface potential difference
to the monolayer observed for most of the stacks may ﬁnd its
explanation by the presence of the small hydrophobic
surfactant-associated protein SP-C. SP-C consists mostly
of an a-helical segment that spans lipid bilayers (25,26).
Alpha-helices exhibit a strong molecular dipole moment
along the helix axis, which, in the case of SP-C, may be
accentuated by positive charges near its N-terminus. SP-C
promotes the formation of lipid bilayer patches and resides in
these multilamellar regions of the surfactant ﬁlms (27). Note
that the absolute contribution of the SP-C to the surface po-
tential of the lipid stacks will be reduced by the screening of
the helical dipole in the lipid environment (28).
If SP-C is indeed the cause for the observed surface
potential of the bilayer stacks, it is not randomly oriented. A
positive surface potential such as observed for the large stacks
is caused when a majority or all SP-C molecules in an area
span the lipid bilayers in a stack with the N-terminus pointing
toward the air. If SP-C is arranged with its C-terminal end
toward the air, the bilayer stacks will be at a more negative
potential than the monolayer such as observed with the small
FIGURE 6 (A) Overview of a ﬁlm of
BLES that contains 20% cholesterol
by weight. Protrusions in the topograph-
ical image (left) are not different in the po-
tential map (right). (B) A high-resolution
map of the topography (left) and potential
(right) of the ﬁlm containing 20%
cholesterol. The perimeter of the small
topographical features were computed
from the topographical image and over-
laid in red on the potential map. The
monolayer is strongly electrically struc-
tured with a dynamic range of up to 300
mV. The length scale of the electrical
domains is ;100 nm. The perimeters
shown in the overlay are enclosing an
area of larger topographical height (i.e.,
larger ﬁlm thickness). In the potential
map, these areas coincidewith the regions
at a more positive surface potential.
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stacks. The extended irregularly shaped bilayer stacks shown
in Fig. 5 Amay have arisen from multiple folding events and/
or the fusion of smaller stacks. This would explain why, in a
region of constant topographical height, the electrical surface
potential sometimes changes in stepwise fashion, as outlined
by the arrows in Fig. 5 A.
SP-B is also present in BLES and also promotes the for-
mation of lamellar structures (29,30). SP-B is likely com-
posed of four to ﬁve amphipathic helices (i.e., helices with a
highly hydrophobic face on the one side and a hydrophilic
face on the opposite side of the helix-axis; for reviews, see
(31,32). It is proposed that the helices are aligned partially
immersed in the lipid layer with the axis parallel to the
interface (33) and act as a cross-linker between monolayer
and bilayer patches. Since the helix-dipoles in this case are
parallel to the interface, they should not contribute to the
surface potential. However, being immersed only in one of
the two leaﬂets of a bilayer might introduce sufﬁcient
asymmetry for a bilayer to show a net surface potential.
The elevated surface potential of the large bilayer stacks
immediately drops by;100 mV outside the perimeter of the
large bilayer stacks (cross sections, Fig. 5 A). Further re-
duction of the potential by ;50–100 mV occurs gradually
over a distance of ;1 mm, indicating that the molecular
composition and order of the monolayer gradually changes
toward the stacks. We have shown earlier that SP-C becomes
gradually inserted from the monolayer into the bilayer stacks
upon area reduction (27,34,35). Hence, SP-C may still be
present also in the monolayer close to the stacks in Fig. 5 and
induce an elevated surface potential. SP-B appears to also be-
come gradually integrated in bilayer stacks upon ﬁlm con-
traction (30) and could have a similar effect. The monolayer
close to the stacks may also have a different lipid composition.
For the ﬁlms containing 20% cholesterol, (Fig. 6), the
occasional protrusions are not at an elevated electrical po-
tential with respect to the monolayer. The absence of a con-
trast in the Kelvin signal in this case may either reﬂect a
disordered molecular arrangement, where molecular dipoles
cancel out, or bilayers devoid of protein. This indicates that
cholesterol inhibits the ordered monolayer-bilayer conver-
sion promoted by SP-B and/or SP-C. Furthermore, unlike in
the absence of cholesterol, the surface potential is also not
altered in the monolayer in proximity to the (rare) protru-
sions. Hence, given the role ascribed to SP-B and/or SP-C in
shaping the surface potential maps of ﬁlms devoid of cho-
lesterol, these proteins may have been lost early on upon
contraction for the ﬁlms containing 20% cholesterol.
At high resolution of the ﬁlms containing 20% cholesterol
(Fig. 6 B), electrical domains in the monolayer region be-
come visible. The domains are ;100 nm across and, hence,
too small to be resolved in the low magniﬁcation map shown
in Fig. 6 A. The dynamic range of the potential of the domains
is ;300 mV. On close inspection, regions of slightly greater
ﬁlm thickness are found to coincide with regions at a more
positive surface potential. Electrical domains of this size are
not present in ﬁlms containing no cholesterol. Hence, cho-
lesterol causes also the lipids in the monolayer to become dif-
ferently arranged. In ﬂuorescence light microscopy, surfactant
containing no cholesterol segregates into domains. Con-
densed domains, typically several micrometers across, are
surrounded by the more ﬂuid components in the ﬁlm (e.g.,
(35–39)). Surfactants containing cholesterol, on the other
hand, appear homogenous by light microscopy (38,39). Our
study now shows that these ﬁlms still form domains, but they
are too small to be resolved in a light microscope. Areas of
higher potential are always found in topographically elevated
areas. Cholesterol promotes a more positive surface potential
in phospholipid ﬁlms (40) and may therefore reside in the
elevated (thicker) ﬁlm areas.
DISCUSSION
Our experimental ﬁndings indicate that the function of pul-
monary surfactant ﬁlms depends on the presence of bilayer
stacks. The stacks are reversibly formed from the monolayer
during ﬁlm contraction and reinsert into the monolayer upon
reexpansion. An elevated level of cholesterol inhibits the
monolayer-bilayer conversion and results in dysfunctional
ﬁlms. In this Discussion, we will attribute the unique me-
chanical properties observed with the functional surfactant
partially to sorting of the surfactant components between the
monolayer and adjacent bilayer patches and partially to
mechanical reinforcement of the ﬁlm by the bilayer stacks.
Sorting
Theminimum surface tension achievable by unsaturated phos-
pholipids is ;20–30 mN/m. DPPC ﬁlms, on the other hand,
can attain near-zero surface tension. Duringmonolayer-bilayer
conversion, unsaturated lipids may be transferred from the
monolayer to the adjacent bilayer patches. The monolayer
may thus become enriched in DPPC, which allows for low
surface tension. If the monolayer-bilayer conversion is in-
hibited by an excess amount of cholesterol, the unsaturated
lipids remain in the monolayer and a low surface tension
cannot be achieved. Instead, the ﬁlm continuously collapses
upon contraction.
The notion of a monolayer-bilayer conversion that also
involves sorting of lipids is supported by the unique prop-
erties of SP-C in conjunction with our experimental ﬁnding of
a deﬁned orientation and polarity of SP-C within the stacks.
Fig. 7 depicts how the orientation of SP-C may become
deﬁned by the two palmitoyl groups close to the N-terminus
during ﬁlm contraction. In this model, the palmitoyl groups
remain anchored in the monolayer while the helix moves to-
gether with the lipids into a newly formed bilayer toward the
aqueous phase. An inverted bilayer patch, formed toward the
air, causes the opposite orientation of the SP-C molecule.
The palmitoyl groups are likely to remain anchored to the
monolayer because of their strong afﬁnity to domains of
condensed, saturated lipids (41). Condensed DPPC domains
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are common for both model and natural surfactant ﬁlms (e.g.,
(42)). In accordance with this proposed role of the palmitoyl
anchor, we found earlier in a model surfactant containing
SP-C that bilayer stacks were always associated with con-
densed regions of a phase-separated monolayer and were
excluded from the more ﬂuid regions of the ﬁlm (43). While
the palmitoyl-groups of the SP-C are likely associated with
DPPC in the monolayer at the air-water interface, the helical
part of the SP-C is known to span lipid bilayers in a ﬂuid
state and is excluded from bilayers in the condensed gel
phase (25). This suggests that SP-C promotes formation of
bilayer patches of unsaturated lipids.
While pulmonary surfactant function may depend on the
monolayer-bilayer conversion to remove unsaturated lipids
from the monolayer, the monolayer-bilayer conversion does
not necessarily depend on the presence of unsaturated lipids.
The conversion occurs even in the presence of only saturated
lipids (DPPC, dipalmitoyl phosphatidyl glycerol) and SP-C
(35) and can be inhibited by an excess amount of cholesterol
as well (44).
Reinforcement
Sorting and a pure or enriched DPPC monolayer alone can-
not fully account for the mechanical stability of a functional
surfactant ﬁlm by itself. Pure DPPC monolayers, while ca-
pable of sustaining a near-zero surface tension, collapse
irreversibly when mechanically disturbed or overcompressed
after reaching close-to-zero surface tension (45). To under-
stand why the monolayer-bilayer conversion is required for
stability at close-to-zero surface tension, the bilayer stacks may
be ascribed a mechanical role, similar to the role of reinforc-
ing elements in preventing a thin plate from collapsing under
lateral compression (46). In this analogy, the surface tension
is equivalent to an external lateral pressure compressing a plate
and the molecular ﬁlm is the continuum plate. The ﬁlm will
buckle above a critical compression. Buckling has been
described as a mode of failure for pulmonary surfactant (47).
Qualitatively, having lipid bilayer patches on the surface
breaks the large areas into smaller patches. According to
elastic theory, the compression above which collapse occurs,
increases strongly with a decrease in size of the elements for
a given cross section (or ﬁlm thickness) (46). For the bilayer
stacks to be mechanically reinforcing, they must be cross-
linked to the monolayer. Otherwise, they will separate from,
or glide over, the monolayer upon area reduction and have no
mechanical effect. In the mechanism for the formation of
stacks proposed above (Fig. 7), SP-C acts as the cross-linker.
We earlier found direct evidence for cross-linkage by SP-C
by mechanically manipulating bilayer stacks in a surfactant
model containing SP-C (43). SP-B is also acting as a cross-
linker, and on its own has led to the formation of bilayer
stacks in a model surfactant ﬁlm of exceptional stability (48).
In agreement with this proposed function of SP-C and SP-B,
artiﬁcial or animal extract surfactants depend on the presence
of either one or both hydrophobic proteins to lower the sur-
face tension to a physiological low level.
Cholesterol inhibits the monolayer-bilayer conversion. It
thus affects both puriﬁcation of the monolayer from unsat-
urated lipid species and reinforcement of the ﬁlm by the bi-
layer stacks. Cholesterol does not appear to cause monolayer
instability independent of these mechanisms. Our earlier
study of surfactant function (13) revealed that BLES ﬁlms can
attain a very low surface tension even in the presence of 20%
cholesterol, if the relative amount of DPPC is also increased
by the same proportion as the cholesterol.We now found that,
under these conditions, the monolayer-bilayer conversion is
still mostly inhibited (not shown). Hence, these ﬁlms may
already contain a sufﬁcient proportion of DPPC to allow for a
low surface tension and may therefore not depend on the
monolayer-bilayer conversion for sorting. However, the func-
tional study (13) also showed that, while attaining a surface
tension close to zero, the ﬁlms were otherwise inferior to a
fully functional ﬁlm. The ﬁlms required an unphysiologically
large amount of area reduction to lower the surface tension
close to zero. They also became dysfunctional after repeated
expansion and compression (13). Hence, similar to pure
DPPC ﬁlms, these ﬁlms lacked stability at near-zero surface
tension. We ascribe lack of stability to the absence of the rein-
forcing bilayer stacks.
FIGURE 7 Mechanism explaining a positive surface potential on the large
bilayer stacks. The helical span of SP-C is oriented in lipid monolayers with
;70 to the normal of the interface (51). Upon ﬁlm contraction, a ﬁrst
bilayer adjacent to the monolayer is formed toward the aqueous subphase.
SP-C rotates to span the newly formed bilayer and remains anchored to the
monolayer by its two palmitoyl groups near its N-terminal end. SP-C is
known to span lipid bilayers (52). As a result, all SP-C molecules face with
the N-terminus toward the air, resulting in a positive surface potential. A
related mechanism (not shown) may occur for the small bilayer stacks that
were found to be at negative electrical surface potential. This time, the
bilayer stacks may form toward the air. With the highly hydrophilic
N-terminus remaining immersed in the water phase, SP-C may now point
with its C-terminus toward the air.
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CONCLUSIONS
An elevated level of cholesterol inhibits the reversible
monolayer-bilayer conversion in pulmonary surfactant and
thus leads to failure of surfactant function. Cholesterol
should therefore become a target for treatment of surfactant
impairment in ARDS. To ﬁnd ways to reverse the effect of
excess cholesterol, future studies will have to address the
mechanism by which cholesterol inhibits the monolayer-
bilayer conversion. An effective treatment, in addition to
countering the effect of cholesterol, may also have to target
other mechanisms of surfactant inhibition, including oxida-
tion of surfactant through the reactive oxygen species present
in the injured lung (7–10,49) and interference with serum
proteins that interact with surfactant (e.g., (50)).
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